Magnetoliposomes in controlled-release drug delivery systems Article

Tomitaka, A, Takemura, Y, Huang, Z et al. (2019). Magnetoliposomes in controlled-release drug delivery systems . CRC CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING, 47(6), 495-505. 10.1615/CritRevBiomedEng.2020033002

cited authors

  • Tomitaka, A; Takemura, Y; Huang, Z; Roy, U; Nair, M

authors

abstract

  • Liposomes, one of the most promising drug delivery carriers, have been extensively studied for the treatment of various diseases and have made their way to the market. Magnetic nanoparticles have been attracting great interest for diagnostic and therapeutic applications due to their unique magnetic properties. An integration of liposomes and magnetic nanoparticles gives great potential to the field of smart drug delivery systems, including magnetically guided drug delivery, image-guided drug delivery, and externally triggered controlled drug release using hyperthermia or alternating magnetic fields. In this review, we discuss the recent development of magnetoliposomes for controlled-release drug delivery systems and their potential.

publication date

  • January 1, 2019

published in

Digital Object Identifier (DOI)

start page

  • 495

end page

  • 505

volume

  • 47

issue

  • 6